A Phase 2 Study of Duvelisib and Venetoclax in Patients with Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) or Richter's Syndrome (RS)Jennifer L. Crombie, Matthew S. Davids, Jon Arnason et al.|Blood|2024Cited by 6
SAVE (Safe Accelerated Venetoclax Escalation): Initial results of a prospective, phase Ib study of venetoclax with an accelerated dose ramp-up in patients with CLL.Jennifer L. Crombie, Matthew S. Davids, Inhye E. Ahn et al.|Journal of Clinical Oncology|2023Cited by 2
A Phase I Study of Copanlisib and Venetoclax in Patients With Relapsed or Refractory Diffuse Large B-Cell LymphomaJennifer L. Crombie, Geoffrey Shouse, Austin I. Kim et al.|Clinical Lymphoma Myeloma & Leukemia|2023Cited by 1
A phase 1/2 study of duvelisib plus venetoclax in patients with relapsed/refractory CLL/SLL or Richter transformationJennifer L. Crombie, Matthew S. Davids, Christine E. Ryan et al.|Blood Advances|2026Cited by 0
SAVE, Safe Accelerated Venetoclax Escalation: A phase Ib study of obinutuzumab plus venetoclax with daily ramp-up in CLLJennifer L. Crombie, Matthew S. Davids, Inhye E. Ahn et al.|Blood Advances|2026Cited by 0